[Usefulness of the addition of aspartate magnesium hydrochloride via intravenous route to beta mimetics in the treatment of threatened premature labor].
Francioli
M
M
De Meuron
A
A
D000328:Adult; D001224:Aspartic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006594:Hexoprenaline / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008274:Magnesium / Q000008:administration & dosage / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D011897:Random Allocation
D001224:Aspartic Acid; D006594:Hexoprenaline; D008274:Magnesium
Estimation de l'utilité de l'adjonction d'aspartate hydrochlorure de magnésium par voie intraveineuse aux bêta-mimétiques dans le traitement de la menace d'accouchement prématuré.